Sigachi Industries Limited — Updates, 23-07-2025: Press Release

Sigachi Industries is bolstering its scientific capabilities with the launch of a new R&D Center in Hyderabad. This strategic move is dedicated to developing high-value Active Pharmaceutical Ingredients (APIs) for global markets. The center, staffed by 32-35 skilled scientists, will drive end-to-end API development from lab innovation to commercialization. This initiative aims to strengthen Sigachi’s backward integration and establish it as a globally competitive supplier in regulated pharmaceutical markets, focusing on priority therapeutic segments for enhanced market access.